The junior market has come of age for long-term private investors

Purchase shows faith in Marks & Spencer turnaround plan

Without real wage growth the UK recovery is likely to stall

Single currency could fall further on poor manufacturing data

There are low-risk ways to back drug developers

House builder’s diversified profile offers continued potential

The ‘devil’s metal’ is adding some welcome spice in a low-volatility world

Blood analyser to hit $900 million market

With mergers and acquisitions firmly back on the corporate agenda, Seán Flynn looks at what is driving the current bout of deals and together with the team highlights some likely prey

In the second follow-up feature looking at fast-growing companies seeking to challenge the elite we focus on the Oil & Gas industry

We assess the impact one year after junior market stocks were allowed into ISAs